Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1622, 2008-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Big Pharma's Recent Challenges
Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. :
Access to resources
Recommend
Drug price cuts in Japan affect big pharma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. :
Conflict-of-interest policies protect docs from big pharma influence
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :
The Big Three of US Pharma: Pfizer, Merck & Co. and GlaxoSmithKline
Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. :
Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department
Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. :